Efficacy and Safety of Zhenyuan Capsule for Coronary Heart Disease with Abnormal Glucose and Lipid Metabolism: Study Protocol for a Randomized, Double-Blind, Parallel-Controlled, Multicenter Clinical Trial.
Yu QiaoJingchun ZhangYue LiuZhiqi LiangYuhua WangWei ZhengDazhuo ShiPublished in: Evidence-based complementary and alternative medicine : eCAM (2018)
This trial is registered with the Chinese Clinical Trials Registry, with identifier number ChiCTR-TRC-14004639, May 4, 2014.